RS 504393 inhibits M-MDSCs recruiting in immune microenvironment of bladder cancer after gemcitabine treatment

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

Bin‐Zhi Qian, Jiufeng Li, Hui Zhang et al. · Nature · 2011 · 2.9K citations · Full text

Medicine, Cancer Biology, Oncology +14

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Hans von der Maase, Steen Werner Hansen, J.T. Roberts et al. · Journal of Clinical Oncology · 2000 · 2.3K citations · Full text

Medicine, Oncology, Pharmacology +11

Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s

Raffaella Bonecchi, Paola Panina‐Bordignon, Daniele D’Ambrosio et al. · The Journal of Experimental Medicine · 1998 · 2K citations · Full text

Life Sciences, Immunology, Cell Signaling +16

Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1

Long Gu, Susan Tseng, Renée M. Horner et al. · Nature · 2000 · 832 citations

Life Sciences, Cell Biology, Immunology +11

CCL2 and Interleukin-6 Promote Survival of Human CD11b+ Peripheral Blood Mononuclear Cells and Induce M2-type Macrophage Polarization

Hernan Roca, Zachary S. Varsos, Sudha Sud et al. · Journal of Biological Chemistry · 2009 · 573 citations · Full text

Life Sciences, Immunology, Oncology +17